ETFsBloomberg US Corporate Liquid Issuer Unhedged USD
Amundi

Amundi Core USD Corporate Bond UCITS ETF Dist

PRIP LSEDistributingPhysical, full replicationLuxembourgNot PEA-eligible
Last close · EUR
15.48EUR
+0.07% · +€0.01
Published closes: 29 Oct 2026 - 30 Oct 2026
30 Oct 2026, close
PRIPBase
Fund charges
0.07%Total expense ratio (TER)
Fund size
€175.1Mall share classes
Return 1Y
-3.4%
Sharpe 3Y
Not published
Volatility 1Y
8.0%annualised
Holdings
2,840Fund holdings

Performance

Compare
  • PRIP-3.4%
  • Price, EUR

Returns

Returns1M3M6MYTD1Y3Y5Y
PRIP+3.9%+2.3%+3.3%+2.4%-3.4%--
MSCI World+0.4%+4.9%+10.8%+16.3%+15.9%+75.5%+71.2%
Gap to MSCI World+3.5%-2.5%-7.5%-13.9%-19.3%--

Risk and return

Sharpe ratio · 1Y
-0.58
Below MSCI World · 1.28
Return p.a.
-2.9%
Volatility
8.0%
Max loss
-7.8%Jan 2026

Sharpe vs indices

MSCI World
1.28
S&P 500
1.16
STOXX Europe 600
0.99
MSCI Emerging Markets IMI
0.76
CAC 40
-0.01
PRIP
-0.58
Method

Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.

Top holdings

Top 10
1.5%
Holdings
2,840
As of
Fund holdings
  1. 1PFIZER INVSTM 5.3% May53US716973AG710.17%
  2. 2META PLATFORM 5.625% Nov55US30303MAE210.16%
  3. 3META PLATFORM 5.25% May36US30303MAH510.16%
  4. 4SKYDANCE CORP 7.05% Oct31US69932AAT250.15%
  5. 5SPACE EXPLORA 5.35% Jul31US84615QAA130.15%
  6. 6WELLS FARGO C VAR Apr51US95000U2M490.15%
  7. 7SPACE EXPLORA 5.65% Jul33US84615QAC780.15%
  8. 8CVS HEALTH CO 5.05% Mar48US126650CZ110.14%
  9. 9ANHEUSER BUSCH 4.9% 01/02/2046US03522AAJ970.14%
  10. 10SPACE EXPLORA 5.875% Jul36US84615QAE350.14%

Countries

Classified 99.4%
Largest
86.9%United States
Top 3
93.4%
Effective number
1.31 / HHI

Market cap

Weight vs holdings

1.5%of the fund sits in the top 10 holdings
  • Holdings 1-10
  • Holdings 11-50
  • Holdings 51-200
  • Holdings 201+

Size split

Not published

Compare ETFs in Copio.

ETF comparison in the Copio app, showing costs and returns with illustrative data.

Factual research, without a suitability score or investment recommendation. Past relationships can change.